US › Healthcare

Hyperion DeFi, Inc. (HYPD)

US · Healthcare · Biotechnology

$2.73+2.63%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$244,271

Revenue YoY

+1559.4%

Net profit

$8.8M

Profit YoY

+353.8%

EPS

$0.26

Net margin

3,619.2%

Key statistics

Market cap

$40.0M

Forward P/E

0.0

P/B

0.68

Book value

$5.12

EPS (TTM)

$-7.55

52-week high

$15.00

52-week low

$2.34

50-day MA

$3.10

200-day MA

$3.87

Beta

2.50

Analyst view

with an average price target of $6.95.

Shareholding

Insiders

14.09%

Institutions

12.27%

Largest institutional holders

Fund	Stake
Morgan Stanley - Brokerage Accounts	1.95%
Redwood Wealth Management Group LLC	1.50%
Jane Street Group LLC	1.05%
Renaissance Technologies Corp	0.95%
Citadel Advisors Llc	0.92%
Vanguard Capital Management, LLC	0.69%
BlackRock Inc	0.66%
Geode Capital Management, LLC	0.63%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hyperion DeFi, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.